Show Summary Details
Page of

Cardiovascular acting agents 

Cardiovascular acting agents
Chapter:
Cardiovascular acting agents
Author(s):

D Nicholas Bateman

, Robert D Jefferson

, Simon HL Thomas

, John P Thompson

, and J Allister Vale

DOI:
10.1093/med/9780199594740.003.0006
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 October 2019

Poisoning with drugs acting on the cardiovascular system may cause major toxicity, and they are increasingly a cause of serious poisoning. The mechanisms by which this occurs arekey to understanding how to approach management and are dealt with in this chapter. Beta antagonists, digoxin, antidysrhythmics, and phosphodiesterase inhibitors principally act on myocardial rhythm and function. Digoxin may cause bradycardia and/or cardiac tachyarrhythmias. Calcium channel antagonists produce a mixed picture in overdose, with direct effects on the heart, including bradycardia and negative inotropic effects, combined with peripheral vasodilatation and metabolic effects such as hyperglycaemia caused by drug effects on insulin release. Hypotension is seen in angiotensin-converting enzyme antagonists,angiotensin-II antagonist, and nitrate poisoning. Newer therapies, including insulin and glucose, are now superseding older treatments for the management of some of these poisonings, in particular calcium channel blocker poisoning. Theophylline is a phosphodiesterase antagonist but poisoning is less common. Cardiac arrhythmias and fits are the usual cause of death after theophylline poisoning.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.